Heterocyclic inhibitors of glutaminase
US9938267B2 · kind B2 · utility
9Cited by
4References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2017 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Sep 11, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.